Montpellier, July 1, 2014 - MEDTECH (Euronext FR0010892950 - ROSA) specialized in the design, development and sales of innovative robotic assistive devices for medical and surgical procedures, has announced the presentation of the first scientific communication on the clinical applications of the ROSA™ Spine robot at the French Society of Spinal Surgery congress.

In this scientific communication entitled “ ROBOT-ASSISTED SPINE SURGERY FOR IMPROVED SAFETY: A PROSPECTIVE CASE-MATCHED ANALYSIS," Dr. Lonjon and his team from the Department of Neurosurgery of the University Hospital of Montpellier highlight the results of the first series of 10 patients operated on with the ROSASpine robot.


During this monocentric pilot study, the ROSA™ Spine robot was used to insert lumbar pedicle screws during an osteosynthesis to treat degenerative lumbar spine disease. The aim of this study was to assess the accuracy of the robotic guidance system.


This scientific communication reports a higher rate of accuracy regarding the placement of the pedicle screws with ROSA™ Spine in 97.3% of patients compared with 92.6% with the conventional method, according to Dr Lonjon. “These preliminary results are encouraging for the development of new robotic techniques for spinal surgery” Dr Lonjon points out.


“These very positive results herald a breakthrough in the field of minimally-invasive robot-assisted spine surgery and, once again, thanks to Medtech’s technological innovation" states Bertin Nahum, CEO and founder of MEDTECH.